Rationalising the treatment of anaemia in cardiac surgery: short and mid-term results from a local quality improvement initiative

BackgroundTransfusion of red blood cells, while often used for treating blood loss or haemodilution, is also associated with higher infection rates and mortality. The authors implemented an initiative to reduce variation in the number of perioperative transfusions associated with cardiac surgery.Met...

Full description

Saved in:
Bibliographic Details
Published inQuality & safety in health care Vol. 19; no. 5; pp. 392 - 398
Main Authors Likosky, Donald S, Surgenor, Stephen D, Dacey, Lawrence J, DeFoe, Gordon R, Maislen, Elizabeth L, Clark, Jean A, Aubuchon, James P, Higgins, John H, Beaulieu, Peter A, O'Connor, Gerald T, Ross, Cathy S
Format Journal Article
LanguageEnglish
Published England BMJ Publishing Group Ltd 01.10.2010
BMJ Publishing Group LTD
Subjects
Online AccessGet full text
ISSN1475-3898
1475-3901
1475-3901
DOI10.1136/qshc.2009.033456

Cover

More Information
Summary:BackgroundTransfusion of red blood cells, while often used for treating blood loss or haemodilution, is also associated with higher infection rates and mortality. The authors implemented an initiative to reduce variation in the number of perioperative transfusions associated with cardiac surgery.MethodsThe authors examined patients undergoing non-emergent cardiac surgery at a single centre from the third quarter 2004 to the second quarter 2007. Phase I focused on understanding the current process of managing and treating perioperative anaemia. Phase II focused on (1) quality-improvement project dissemination to staff, (2) developing and implementing new protocols, and (3) assessing the effect of subsequent interventions. Data reports were updated monthly and posted in the clinical units. Phase III determined whether reductions in transfusion rates persisted.ResultsIndications for transfusions were investigated during Phase II. More than half (59%) of intraoperative transfusions were for low haematocrit (Hct), and 31% for predicted low Hct during cardiopulmonary bypass. 43% of postoperative transfusions were for low Hct, with an additional 16% for failure to diurese. The last Hct value prior to transfusion was noted (Hct 25–23, p=0.14), suggestive of a higher tolerance for a lower Hct by staff surgeons. Intraoperative transfusions diminished across phases: 33% in Phase I, 25.8% in Phase II and 23.4% in Phase III (p<0.001). Relative to Phase I, postoperative transfusions diminished significantly over Phase II and III.ConclusionsWe report results from a focused quality-improvement initiative to rationalise treatment of perioperative anaemia. Transfusion rates declined significantly across each phase of the project.
Bibliography:istex:7BFB383419662EFE78316C7CD3EE83A0BA025B4B
href:qhc-19-392.pdf
local:qhc;19/5/392
ArticleID:qhc33456
ark:/67375/NVC-8QX7XQFG-W
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1475-3898
1475-3901
1475-3901
DOI:10.1136/qshc.2009.033456